Showing results (71-80 of 671) with videos related to
Sort By:
Pageof 68
Circulation|February 18, 1997
Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targetingC Bode, S R Hanson, J F Schmedtje, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activationB H Chao, J A Jakubowski, B Savage, et al.Hypertension (Dallas, Tex. : 1979)|October 1, 1991
Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboonS R Hanson, J S Powell, T Dodson, et al.The Journal of Heart Valve Disease|April 12, 2001
The sensitivity of indicators of thrombosis initiation to a bileaflet prosthesis leakage stimulusB R Travis, U M Marzec, J T Ellis, et al.Blood|January 1, 1997
Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factorL A Harker, U M Marzec, A B Kelly, et al.Blood|June 1, 1994
Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primatesY Cadroy, S R Hanson, A B Kelly, et al.Circulation|September 1, 1979
Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapyL A Harker, W HazzardAdvances in Experimental Medicine and Biology|January 1, 1978
Vessel injury, thrombosis, and platelet survivalL A Harker, R RossJournal of the American College of Cardiology|December 1, 1986
Pharmacology of platelet inhibitorsL A Harker, V FusterCirculation|August 5, 1997
Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primatesI B Sundell, U M Marzec, A B Kelly, et al.Pageof 68